Insider Transactions in Q3 2025 at Edgewise Therapeutics, Inc. (EWTX)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 12
2025
|
Joanne M. Donovan CMO |
SELL
Open market or private sale
|
Direct |
2,862
-10.14%
|
$37,206
$13.39 P/Share
|
|
Aug 12
2025
|
Joanne M. Donovan CMO |
BUY
Exercise of conversion of derivative security
|
Direct |
5,781
+17.0%
|
-
|
|
Aug 12
2025
|
Kevin Koch President and CEO |
SELL
Open market or private sale
|
Direct |
7,972
-20.66%
|
$103,636
$13.39 P/Share
|
|
Aug 12
2025
|
Kevin Koch President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,968
+31.77%
|
-
|
|
Aug 12
2025
|
Alan J Russell Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,907
-7.54%
|
$24,791
$13.39 P/Share
|
|
Aug 12
2025
|
Alan J Russell Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,781
+18.6%
|
-
|
|
Aug 12
2025
|
R Michael Carruthers Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,428
-1.63%
|
$18,564
$13.39 P/Share
|
|
Aug 12
2025
|
R Michael Carruthers Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,781
+6.19%
|
-
|
|
Aug 12
2025
|
Behrad Derakhshan Chief Business Officer |
SELL
Open market or private sale
|
Direct |
2,491
-9.53%
|
$32,383
$13.39 P/Share
|
|
Aug 12
2025
|
Behrad Derakhshan Chief Business Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,781
+18.11%
|
-
|
|
Aug 12
2025
|
John R Moore General Counsel |
SELL
Open market or private sale
|
Direct |
2,098
-17.04%
|
$27,274
$13.39 P/Share
|
|
Aug 12
2025
|
John R Moore General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
5,781
+31.95%
|
-
|
|
Jul 01
2025
|
Jonathan C Fox |
BUY
Grant, award, or other acquisition
|
Direct |
858
+6.53%
|
-
|